Literature DB >> 32306488

Hyperammonemia syndrome due to Ureaplasma infection after liver-kidney transplant.

Chase A Cannon1, Maria A Corcorran1, Kathryn W Shaw2, Martin Montenovo2, Lena Sibulesky2, Jorge D Reyes2, Stephen C Rayhill2, Anne M Larson3, Patricia A Kritek4, Shewit Giovanni4, Iris de Castro5, Nayan Arora5, Robert M Rakita1.   

Abstract

Hyperammonemia syndrome, with high levels of ammonia and neurologic dysfunction, is a syndrome with historically high mortality that may occur after solid organ transplantation. Recently, this has been associated with infection due to Ureaplasma, mostly following lung transplantation. We describe the first case of hyperammonemia syndrome due to Ureaplasma infection after liver-kidney transplantation. Our patient rapidly recovered after specific antibiotic treatment. It is important to consider these infections in the differential diagnosis for encephalopathy post-transplant, as these organisms often do not grow using routine culture methods and polymerase chain reaction testing is typically required for their detection. This is particularly critical after liver transplantation, where a number of other etiologies may be considered as a cause of hyperammonemia syndrome.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Ureaplasmazzm321990; hyperammonemia; liver transplantation

Mesh:

Substances:

Year:  2020        PMID: 32306488      PMCID: PMC7292677          DOI: 10.1111/tid.13298

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  17 in total

1.  Fatal hyperammonaemia caused by Mycoplasma hominis.

Authors:  Mark E Wylam; Cassie C Kennedy; Nina M Hernandez; Steve G Peters; Joseph J Maleszewski; Stephen D Cassivi; John P Scott
Journal:  Lancet       Date:  2013-12-07       Impact factor: 79.321

2.  Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.

Authors:  Ankit Bharat; Scott A Cunningham; G R Scott Budinger; Daniel Kreisel; Charl J DeWet; Andrew E Gelman; Ken Waites; Donna Crabb; Li Xiao; Sangeeta Bhorade; Namasivayam Ambalavanan; Daniel F Dilling; Erin M Lowery; Todd Astor; Ramsey Hachem; Alexander S Krupnick; Malcolm M DeCamp; Michael G Ison; Robin Patel
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

3.  Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States.

Authors:  Javier Fernández; Melissa J Karau; Scott A Cunningham; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

4.  Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model.

Authors:  X Wang; K E Greenwood-Quaintance; M J Karau; D R Block; J N Mandrekar; S A Cunningham; J M Mallea; R Patel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-28       Impact factor: 3.267

5.  Noncirrhotic hyperammonemia after deceased donor kidney transplantation: A case report.

Authors:  George Z Li; Maria C Tio; Linda M Pak; Joel Krier; Julian L Seifter; Stefan G Tullius; Leonardo V Riella; Sayeed K Malek; Andrew B Stergachis
Journal:  Am J Transplant       Date:  2019-09-12       Impact factor: 8.086

Review 6.  Idiopathic hyperammonemia after solid organ transplantation: Primarily a lung problem? A single-center experience and systematic review.

Authors:  Dustin Krutsinger; Alejandro Pezzulo; Amy E Blevins; Robert M Reed; Michael D Voigt; Michael Eberlein
Journal:  Clin Transplant       Date:  2017-04-07       Impact factor: 2.863

7.  Hiding in Plain Sight: A Case of Ornithine Transcarbamylase Deficiency Unmasked Post-Liver Transplantation.

Authors:  M Ramanathan; S Uppalapu; N M Patel
Journal:  Am J Transplant       Date:  2017-02-06       Impact factor: 8.086

8.  Hyperammonemia following allogeneic bone marrow transplantation.

Authors:  N Tse; S Cederbaum; J A Glaspy
Journal:  Am J Hematol       Date:  1991-10       Impact factor: 10.047

9.  Endovascular diagnosis and intervention in patients with isolated hyperammonemia, with or without ascites, after liver transplantation.

Authors:  Alexander Belenky; Igor Igov; Youval Konstantino; Gil N Bachar; Eitan Mor; Franklyn Graif; Ziv Ben-Ari; Ran Tur-Kaspa; Eli Atar
Journal:  J Vasc Interv Radiol       Date:  2008-12-20       Impact factor: 3.464

10.  In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.

Authors:  R Krausse; S Schubert
Journal:  Clin Microbiol Infect       Date:  2010-11       Impact factor: 8.067

View more
  4 in total

1.  Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.

Authors:  Scott C Roberts; Ankit Bharat; Chitaru Kurihara; Rade Tomic; Michael G Ison
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

Review 2.  Hyperammonemia syndrome in immunosuppressed individuals.

Authors:  Scott C Roberts; Waleed Malik; Michael G Ison
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

Review 3.  Hyperammonemia After Lung Transplantation: Systematic Review and a Mini Case Series.

Authors:  Amir Y Kamel; Amir M Emtiazjoo; Lauren Adkins; Abbas Shahmohammadi; Hassan Alnuaimat; Andres Pelaez; Tiago Machuca; Mauricio Pipkin; Hyun-Wook Lee; I David Weiner; Satish Chandrashekaran
Journal:  Transpl Int       Date:  2022-05-03       Impact factor: 3.842

4.  A novel cause of emergent hyperammonemia: Cryptococcal fungemia and meningitis.

Authors:  William B Hannah; Gregory Nizialek; Katherine J Dempsey; Keith B Armitage; Shawn E McCandless; Laura L Konczal
Journal:  Mol Genet Metab Rep       Date:  2021-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.